Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.440
-0.030 (-2.04%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Boundless Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 18.71 | 18 | 12.16 | 9.31 | 6.02 |
| Research & Development | 44.85 | 55.27 | 42.64 | 37.16 | 19.28 |
| Operating Expenses | 63.55 | 73.27 | 54.8 | 46.47 | 25.3 |
| Operating Income | -63.55 | -73.27 | -54.8 | -46.47 | -25.3 |
| Interest & Investment Income | 5.36 | 7.89 | 5.28 | 0.67 | 0.1 |
| Other Non Operating Income (Expenses) | -0 | 0.01 | 0.08 | -0.1 | -0.01 |
| Pretax Income | -58.2 | -65.36 | -49.43 | -45.9 | -25.21 |
| Net Income | -58.2 | -65.36 | -49.43 | -45.9 | -25.21 |
| Net Income to Common | -58.2 | -65.36 | -49.43 | -45.9 | -25.21 |
| Shares Outstanding (Basic) | 22 | 17 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 22 | 17 | 1 | 1 | 1 |
| Shares Change (YoY) | 31.65% | 1296.71% | 10.77% | 27.56% | - |
| EPS (Basic) | -2.60 | -3.85 | -40.65 | -41.81 | -29.29 |
| EPS (Diluted) | -2.60 | -3.85 | -40.65 | -41.81 | -29.29 |
| Free Cash Flow | -47.21 | -63.38 | -47.49 | -40.66 | -25.28 |
| Free Cash Flow Per Share | -2.11 | -3.73 | -39.05 | -37.04 | -29.38 |
| EBITDA | -62.3 | -72.18 | -53.84 | -45.53 | -24.62 |
| D&A For EBITDA | 1.25 | 1.09 | 0.96 | 0.94 | 0.68 |
| EBIT | -63.55 | -73.27 | -54.8 | -46.47 | -25.3 |
Source: S&P Capital IQ. Standard template.
Financial Sources.